Our sister site, Drug Delivery Business News, reports that Abbott made its Lingo CGM system available without a prescription in the U.S.
Lingo features a biosensor and mobile app designed for customers who want to improve their overall health and wellness. The company built Lingo on its FreeStyle Libre CGM technology platform.
Abbott received FDA clearance for Lingo and its Libre Rio over-the-counter (OTC) CGMs in June. The launch highlights the industry’s move beyond prescription CGMs, as Dexcom also launched its own Stelo OTC CGM last week.
Lingo, a consumer biowearable, is available for consumers 18 years and older not on insulin. It tracks glucose in real time and provides personal insights and coaching. Abbott designed it to help people build healthy habits, retain their metabolism and improve their overall wellbeing.
Get the full story at our sister site, Drug Delivery Business News.
